HCW Biologics (HCWB) Capital Expenditures (2020 - 2024)
HCW Biologics' (HCWB) quarterly Capital Expenditures came in at $113412.0 in Q4 2024, down 94.71% YoY from $2.1 million in Q1 2024, and up 206.0% on a QoQ basis from $37063.0 in Q3 2024.
HCW Biologics (HCWB) Capital Expenditures (2020 - 2024) Analysis & Trends
HCW Biologics (HCWB) has 5 years of Capital Expenditures data on file, last reported at $113412.0 in Q4 2024.
- Quarterly Capital Expenditures fell 94.71% year-over-year to $113412.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $113412.0 (down 95.05% YoY) and the FY2024 annual result came in at $261617.0, down 93.83% from the prior year.
- Capital Expenditures rose to $113412.0 in Q4 2024, from $37063.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $10.2 million in Q3 2022 to a low of -$10.2 million in Q4 2022.
- A 5-year average of $293192.4 and a median of $36727.0 in 2020 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 246909.7% in 2022, down 51512.66% in 2022.
- Tracing HCWB's Capital Expenditures over 5 years: stood at $36391.0 in 2020, then tumbled by 45.45% to $19852.0 in 2021, then tumbled by 51512.66% to -$10.2 million in 2022, then soared by 121.01% to $2.1 million in 2023, then tumbled by 94.71% to $113412.0 in 2024.
- The last three Capital Expenditures figures came in at $113412.0 (Q4 2024), $37063.0 (Q3 2024), and -$2.1 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 113,412.00 |
| Dec 31, 2024 | 113,412.00 |
| Sep 30, 2024 | 37,063.00 |
| Sep 30, 2024 | 37,063.00 |
| Jun 30, 2024 | -2.08 Mn |
| Jun 30, 2024 | -2.08 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 238,824.00 |
| Sep 30, 2023 | 238,824.00 |
| Jun 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 1.86 Mn |
| Dec 31, 2022 | -10.21 Mn |
| Dec 31, 2022 | -10.21 Mn |
| Sep 30, 2022 | 10.21 Mn |
| Sep 30, 2022 | 10.21 Mn |
| Jun 30, 2022 | -23,554.00 |
| Jun 30, 2022 | -23,554.00 |